CYP21A2 and congenital adrenal hyperplasia: Several cohort studies have found genotype‐to‐phenotype associations linking CYP21A2 mutations to a variety of CAH phenotypes (de Carvalho et al., 2016; Soardi et al., 2008; Torres et al., 2003).